Current perspectives on the dysregulated microRNAs in gastric cancer

被引:9
作者
Azarbarzin, Shirin [1 ]
Safaralizadeh, Reza [1 ]
Khojasteh, Mahdi Banan [1 ]
Baghbanzadeh, Amir [2 ]
Baradaran, Behzad [2 ]
机构
[1] Univ Tabriz, Fac Nat Sci, Dept Anim Biol, Tabriz, Iran
[2] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
关键词
Angiogenesis; Gastric cancer; Invasion; Migration; miRNAs; Proliferation; INHIBITS CELL-PROLIFERATION; DRUG-RESISTANCE; MULTIDRUG-RESISTANCE; INTESTINAL-TYPE; POTENTIAL BIOMARKER; APOPTOSIS; SUPPRESSES; MIGRATION; ANGIOGENESIS; INVASION;
D O I
10.1007/s11033-020-05720-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since gastric cancer (GC) is diagnosed at advanced stages, the survival rate is low in affected people. In this regard, investigating the mechanisms underlying GC development, are so critical. MiRNAs, which are small non coding RNAs, as a post transcriptional repressor, regulate expression of target genes by stimulating breakage or transcription suppression of their targets therefore aberrant expression of miRNAs leading to GC carcinogenesis. In the last decades, there have been various studies approving the pivotal role of miRNAs in various phases of GC development including cancer initiation, proliferation, migration, invasion, metastasis, angiogenesis, apoptosis, and drug resistance. Therefore, the present review aimed at summarizing the dysregulated miRNAs which contribute to various cellular and developmental mechanisms such as, proliferation, apoptosis, invasion, migration, and angiogenesis. Moreover, it provides an overview on novel miRNAs involved in drug resistance and circular miRNAs as cancer biomarkers. Thereafter, it is hoped that the present study will shed more light on diagnostic and prognostic biomarkers of GC, and potential GC treatments based on miRNAs.
引用
收藏
页码:7253 / 7264
页数:12
相关论文
共 98 条
  • [1] [Anonymous], 2002, PDQ Cancer Inf. Summ
  • [2] The Value of MiR-383, an Intronic MiRNA, as a Diagnostic and Prognostic Biomarker in Intestinal-Type Gastric Cancer
    Azarbarzin, Shirin
    Feizi, Mohammad Ali Hosseinpour
    Safaralizadeh, Reza
    Kazemzadeh, Mina
    Fateh, Alavieh
    [J]. BIOCHEMICAL GENETICS, 2017, 55 (03) : 244 - 252
  • [3] Reduced expression of miR-411 in intestinal type of gastric adenocarcinoma
    Azarbarzin, Shirin
    Feizi, Mohammad Ali Hosseinpour
    Safaralizadeh, Reza
    Ravanbakhsh, Reyhaneh
    Karimi, Nasibeh
    Kazemzadeh, Mina
    Fateh, Alavieh
    Sadat, Amir Taher Eftekhar
    Somi, Mohammad Hossein
    [J]. META GENE, 2016, 10 : 23 - 26
  • [4] The Value of miR-299-5p in Diagnosis and Prognosis of Intestinal-Type Gastric Adenocarcinoma
    Azarbarzin, Shirin
    Feizi, Mohammad Ali Hosseinpour
    Safaralizadeh, Reza
    Ravanbakhsh, Reyhaneh
    Kazemzadeh, Mina
    Fateh, Alavieh
    Karimi, Nasibeh
    Moaddab, Yaghoub
    [J]. BIOCHEMICAL GENETICS, 2016, 54 (04) : 413 - 420
  • [5] miRNA control of tumor cell invasion and metastasis
    Baranwal, Somesh
    Alahari, Suresh K.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (06) : 1283 - 1290
  • [6] Regulation of drug resistance and metastasis of gastric cancer cells via the microRNA647-ANK2 axis
    Cao, Wenlong
    Wei, Weiyuan
    Zhan, Zexu
    Xie, Dongyi
    Xie, Yubo
    Xiao, Qiang
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (04) : 1958 - 1966
  • [7] MicroRNA-140-5p suppresses cell proliferation and invasion in gastric cancer by targeting WNT1 in the WNT/β-catenin signaling pathway
    Cha, Yinlian
    He, Ying
    Ouyang, Kaobin
    Xiong, Hailin
    Li, Jun
    Yuan, Xia
    [J]. ONCOLOGY LETTERS, 2018, 16 (05) : 6369 - 6376
  • [8] Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method or Gastric Cancer Screening
    Chen, Xian-Zhe
    Huang, Cheng-Zhi
    Hu, Wei-Xian
    Liu, Ying
    Yao, Xue-Qing
    [J]. CHINESE MEDICAL JOURNAL, 2018, 131 (10) : 1232 - 1239
  • [9] Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance
    Danza, Katia
    Silvestris, Nicola
    Simone, Giovanni
    Signorile, Michele
    Saragoni, Luca
    Brunetti, Oronzo
    Monti, Manlio
    Mazzotta, Annalisa
    De Summa, Simona
    Mangia, Anita
    Tommasi, Stefania
    [J]. CANCER BIOLOGY & THERAPY, 2016, 17 (04) : 400 - 406
  • [10] Targeting EMT in cancer: opportunities for pharmacological intervention
    Davis, Felicity M.
    Stewart, Teneale A.
    Thompson, Erik W.
    Monteith, Gregory R.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2014, 35 (09) : 479 - 488